Missed the Collaborative Cancer Grand Rounds lecture Feb. 27 by National Cancer Institute Deputy Director Douglas R. Lowy, MD, in the University of Arizona Cancer Center’s Kiewit Auditorium?
No worries. Find the link to archived video from his presentation here: https://streaming.biocom.arizona.edu/event/?id=28048
You also can see a photo gallery from his talk at the UA Department of Medicine’s Facebook webpage at this link.
Dr. Lowy was introduced by UA Cancer Center Director Andrew S. Kraft, MD, who is also a professor of medicine in the UA Divison of Hematology and Oncology, senior associate dean for Translational Research, UA College of Medicine – Tucson, associate vice president for Oncology Programs, UA Health Sciences, and the Sydney E. Salmon Endowed Chair, University of Arizona.
Attendance at the event was such that extra chairs had to be brought in to accommodate those who wanted to hear Dr. Lowy speak.
Dr. Lowy is the former acting director of the U.S. National Cancer Institute (NCI) and chief of the Laboratory of Cellular Oncology within the Center for Cancer Research at NCI. He was named acting director on April 1, 2015, and served as NCI deputy director from 2010 to 2015, and again beginning in October 2017. He was co-recipient (along with Dr. John T. Schiller) of the National Medal of Technology and Innovation in 2014.
Dr. Lowy received his medical degree from the New York University School of Medicine, and trained in internal medicine at Stanford University and dermatology at Yale. He has directed a research laboratory at NCI since 1975, after receiving training as a Research Associate in the National Institute of Allergy and Infectious Diseases. His and Dr. Schiller’s research focuses on characterization of the HPV oncoproteins E6 and E7.
Dr. Lowy is a member of the National Academy of Sciences and of its Institute of Medicine. For his joint research with Dr. Schiller on technology that enabled development of preventive human papillomavirus (HPV) vaccines, they received the 2007 Samuel J. Heyman Service to America Medal, the 2011 Albert B. Sabin Gold Medal, as well as the National Medal of Technology and Innovation (2012 medal awarded in 2014). He also has received the National Medal of Honor for Basic Research from the American Cancer Society.
Among attendees at his UA Cancer Center address were Julie Bauman, MD, MPH, chief, Division of Hematology and Oncology; Daruka Mahadevan, MD, PhD, director, UA Cancer Center's Phase I Clinical Trials Program; Steven J. Wang, MD, chair, Department of Otolaryngology – Head and Neck Surgery; Elizabeth Calhoun, PhD, associate vice president, population health sciences, and executive director, Center for Population Science and Discovery, at the UA Health Sciences, and co-principal investigator on the All of Us℠ Arizona Research Program/Precision Medicine Initiative; and David Albert, MD, retired director emeritus, UA Cancer Center.
—David Mogollón